KYMRIAH 1,2 X 10E6 A 6 X 10E8 CEL EM DISP INF 1 A 3 BOLS PLAS TRANS 10 ML A 50 ML

Presentation · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brazil

  • Registration number 1006811800010
  • GGREM 526522060100607

What the source publishes

Holder
NOVARTIS BIOCIENCIAS S.A
Active ingredients
TISAGENLECLEUCEL
Package
1,2 X 10E6 A 6 X 10E8 CEL EM DISP INF 1 A 3 BOLS PLAS TRANS 10 ML A 50 ML
Supply regime
Tarja Vermelha
Product type
Produto de Terapia Avançada
Therapeutic class
L1X9 - TODOS OS OUTROS ANTINEOPLÁSICOS
Prescription
Prescription or restricted

Names this record is found by

Complete source data
br:cmed:presentations:526522060100607
{
  "name": "KYMRIAH 1,2 X 10E6 A 6 X 10E8 CEL EM DISP INF 1 A 3 BOLS PLAS TRANS 10 ML A 50 ML",
  "holder": "NOVARTIS BIOCIENCIAS S.A",
  "stripe": "Tarja Vermelha",
  "barcodes": [
    "0000000000000"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "526522060100607",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "56.994.502/0001-30",
  "priceRegime": "Regulado",
  "productName": "KYMRIAH",
  "productType": "Produto de Terapia Avançada",
  "hospitalOnly": true,
  "presentation": "1,2 X 10E6 A 6 X 10E8 CEL EM DISP INF  1 A 3 BOLS PLAS TRANS 10 ML A 50 ML",
  "sourceStatus": null,
  "supplyRegime": "Tarja Vermelha",
  "factoryPrices": {
    "icms-0": "1676936.00",
    "icms-12": "1905609.70",
    "icms-17": "2020404.35",
    "icms-18": "2045043.58",
    "icms-19": "2070291.52",
    "icms-20": "2096170.00",
    "icms-21": "2122704.16",
    "icms-22": "2149917.48",
    "icms-23": "2177838.46",
    "icms-17.5": "2032649.34",
    "icms-19.5": "2083150.27",
    "icms-20.5": "2109354.07",
    "icms-22.5": "2163789.09",
    "icms-12-alc": "1701437.71",
    "icms-17-alc": "1803932.04",
    "icms-18-alc": "1825931.76",
    "icms-19-alc": "1848473.14",
    "icms-20-alc": "1871579.64",
    "icms-21-alc": "1895271.39",
    "icms-22-alc": "1919568.52",
    "icms-23-alc": "1944497.85",
    "withoutTaxes": "1497264.05",
    "icms-17.5-alc": "1814865.66",
    "icms-19.5-alc": "1859955.12",
    "icms-20.5-alc": "1883350.05",
    "icms-22.5-alc": "1931952.69"
  },
  "pisCofinsList": "Negativa",
  "substanceText": "TISAGENLECLEUCEL",
  "targetSpecies": [],
  "consumerPrices": null,
  "invalidBarcodes": [
    "0000000000000"
  ],
  "activeSubstances": [
    "TISAGENLECLEUCEL"
  ],
  "therapeuticClass": "L1X9 - TODOS OS OUTROS ANTINEOPLÁSICOS",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1006811800010",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "prescription-or-restricted",
  "prescriptionRequired": true,
  "therapeuticClassCode": "L1X9",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:526522060100607"